BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11235170)

  • 1. [Genetic analysis of endometriosis and ovarian cancer].
    Obata K; Hoshiai H
    Nihon Rinsho; 2001 Jan; 59 Suppl 1():217-20. PubMed ID: 11235170
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
    Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common genetic changes between endometriosis and ovarian cancer.
    Obata K; Hoshiai H
    Gynecol Obstet Invest; 2000; 50 Suppl 1():39-43. PubMed ID: 11093060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An approach to early genetic alterations in precancerous cells].
    Sato N; Nishida M; Noguchi M
    Hum Cell; 2000 Sep; 13(3):103-8. PubMed ID: 11197771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
    Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG
    Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenic role of PTEN tumor suppressor gene in ovarian cancer associated to endometriosis].
    Castiblanco G A; Pires N Y; Wistuba O I; Riquelme S E; Andrade M L; Corvalán R A
    Rev Med Chil; 2006 Mar; 134(3):271-8. PubMed ID: 16676097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correspondence re: W.M. Lin et al., loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas. Clin. Cancer Res., 4: 2577-2583, 1998.
    Matias-Guiu X; Bussaglia E; Catasus L; Lagarda H; Gras E; Machin P; Prat J
    Clin Cancer Res; 2000 Apr; 6(4):1598-600. PubMed ID: 10778994
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis.
    Xu B; Hamada S; Kusuki I; Itoh R; Kitawaki J
    Gynecol Oncol; 2011 Feb; 120(2):239-46. PubMed ID: 21130491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas.
    Catasús L; Bussaglia E; Rodrguez I; Gallardo A; Pons C; Irving JA; Prat J
    Hum Pathol; 2004 Nov; 35(11):1360-8. PubMed ID: 15668893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathology of ovarian cancer.
    Sanseverino F; D'Andrilli G; Petraglia F; Giordano A
    Anal Quant Cytol Histol; 2005 Jun; 27(3):121-4. PubMed ID: 16121632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
    Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
    Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ovarian cancers complicated by endometriosis].
    Obata K; Koike H; Shiina M
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():615-22. PubMed ID: 15535319
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of p53 mutation in the carcinomas arising from endometriosis.
    Akahane T; Sekizawa A; Purwosunu Y; Nagatsuka M; Okai T
    Int J Gynecol Pathol; 2007 Jul; 26(3):345-51. PubMed ID: 17581423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The malignant potential of ovarian atypical endometriosis].
    Guo L; Liu T; Lang J
    Zhonghua Bing Li Xue Za Zhi; 2001 Jun; 30(3):169-72. PubMed ID: 11866970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometriosis-associated Ovarian Cancers.
    Anglesio MS; Yong PJ
    Clin Obstet Gynecol; 2017 Dec; 60(4):711-727. PubMed ID: 28990985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetic evidence that endometriosis is a precursor of ovarian cancer.
    Prowse AH; Manek S; Varma R; Liu J; Godwin AK; Maher ER; Tomlinson IP; Kennedy SH
    Int J Cancer; 2006 Aug; 119(3):556-62. PubMed ID: 16506222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic defects in endometriosis.
    Thomas EJ; Campbell IG
    Gynecol Obstet Invest; 2000; 50 Suppl 1():44-50. PubMed ID: 11093061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of mutation and expression of PTEN gene mRNA on tumorigenesis and progression of epithelial ovarian cancer.
    Chen Y; Zheng H; Yang X; Sun L; Xin Y
    Chin Med Sci J; 2004 Mar; 19(1):25-30. PubMed ID: 15104221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometriosis-associated ovarian carcinomas.
    Nissenblatt M
    N Engl J Med; 2011 Feb; 364(5):482-3; author reply 484-5. PubMed ID: 21288105
    [No Abstract]   [Full Text] [Related]  

  • 20. Endometriosis and the neoplastic process.
    Varma R; Rollason T; Gupta JK; Maher ER
    Reproduction; 2004 Mar; 127(3):293-304. PubMed ID: 15016949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.